The Academy's Basic and Clinical Science Course™ is ophthalmology’s definitive source of clinical information. Practicing ophthalmologists and residents worldwide use the BCSC® to ensure the highest-quality patient care. Each of the 13 volumes includes up-to-date clinical knowledge, concise information, tables, self-assessment questions with answers, photos and illustrations and opportunities for earning AMA PRA Category 1 Credit™.
Beginning with the 2013–2014 edition, the Academy and the European Board of Ophthalmology (EBO) have partnered to make the BCSC® the standard text for all European ophthalmology training programs. The EBO now recommends the BCSC® as the primary educational resource for European trainees and ophthalmologists studying for the annual EBO Diploma Exam.
Section 4 presents materials in two parts: Part I, Ophthalmic Pathology; and Part II, Intraocular Tumors.
Part I uses a hierarchy that moves from general to specific to help derive a differential diagnosis for a specific tissue.
Part II is a compilation of selected clinical aspects of importance to the general ophthalmologist – this section contains an extensive discussion on intraocular tumors.
Includes two interactive features that identify the disease process and cell type, expanded content on specimen handling, updated photographs and illustrations throughout plus key takeaways highlighted at the beginning of each chapter.
Additionally, this section has a variety of images and videos that deepen your understanding.
Upon completion of Section 4, readers should be able to:
• Use a hierarchical framework of topography, disease process, and differential diagnosis to understand major ocular conditions.
• Summarize the steps for handling ocular specimens for pathologic study.
• Explain the basic principles of special procedures and diagnostic testing used in ophthalmic pathology.
• State the main histologic features of common ocular conditions.
• Identify those ophthalmic lesions that indicate systemic disease and are potentially life threatening
• Describe the methodologies used for intraocular tumor diagnosis; treatment modalities for ocular tumors; and important genetic information for families affected by retinoblastoma.
Last Major Revision: 2020-2021